Nathan Elner

• Twin Star International, Inc. as the stalking horse purchaser in the pre-arranged Chapter 11 Cases of Walker Edison Holdco LLC and certain of its affiliates in the U.S. Bankruptcy Court for the District of Delaware. *
• Represented OYA Renewables and seven affiliates (collectively, “OYA”) in their Chapter 11 cases pending in front of the U.S. Bankruptcy Court for the District of Delaware. OYA developed large-scale commercial solar projects. The Court has approved the sale of substantially all of OYA’s assets under Bankruptcy Code Section 363. *
• Represented Independence Contract Drilling, Inc. (“ICD”) in its Chapter 11 pre-packaged restructuring process, lending to ICD successfully emerging as a private company that is financially and operationally stronger and well-positioned for the future. The U.S. Bankruptcy Court for the Southern District of Texas confirmed ICD’s Plan of Reorganization in January 2025, only one month after the initiation of the Chapter 11 proceedings. *
• Counsel to Conn’s Inc. and its affiliates, an iconic American appliance and furniture retailer throughout 16 states, in their Chapter 11 proceedings pending in the U. S. Bankruptcy Court for the Southern District of Texas. As part of its restructuring, Conn’s was authorized to conduct store closing sales of approximately 550 retail stores, using proceeds to fund operations and repay its DIP financing. *
• ICON Aircraft, Inc. in its filing for Chapter 11 protection in the United States Bankruptcy Court for the District of Delaware, citing more than US$170 million in debt. *
• Eiger Biopharmaceuticals, Inc., a Palo Alto, California-based biopharmaceutical company that developed treatments for rare metabolic diseases, in its Chapter 11 cases in the U.S. Bankruptcy Court for the Northern District of Texas through asset sales and a consensual plan of liquidation, resulting in the prepetition secured lender and unsecured creditors being paid in full and distributions being made to equity. *
• Stonepeak Infrastructure Partners in connection with the restructuring of Akumin, Inc. Stonepeak’s unsecured note was equitized into 100% of Akumin’s common equity in connection with a Chapter 11 process in the Southern District of Texas. *
• Impel Pharmaceuticals, a commercial-stage drug developer with an emphasis on treating central nervous system conditions using a proprietary nasal drug delivery apparatus, and one of its subsidiaries in their Chapter 11 cases in the U.S. Bankruptcy Court for the Northern District of Texas. *
• Represented Accelerate Diagnostics, Inc. in connection with the out-of-court restructuring of its matured bond debt. Accelerate Diagnostics, Inc. Accelerate Diagnostics is a diagnostics company focused on antibiotic resistance and sepsis in the hospital setting. *
• Reverse Mortgage Investment Trust Inc. in their Chapter 11 bankruptcy cases in the U.S. Bankruptcy Court for the District of Delaware. RMIT was a leading fully integrated financing company that focused on the reverse mortgage industry, with a servicing portfolio of approximately US$25.57 billion as of October 31, 2022. With over US$1.4 billion in funded debt obligations, RMIT’s Chapter 11 cases were among the largest filed in 2022. *

* Experience occurred prior to joining Dorsey.